Abstract
This systematic review investigates the application of Artificial Intelligence (AI) in the prediction of cancer prognosis, with an emphasis on the personalization of treatments. We analyzed 78 studies that used AI algorithms, such as Convolutional Neural Networks (CNNs) and Support Vector Machines (SVMs), in breast, lung, colorectal, and prostate cancers. The main outcomes addressed recurrence, survival, and therapeutic response. The results demonstrated that AI improves accuracy in identifying relapses and predicting treatment response, facilitating personalized interventions. However, the heterogeneity of the data and the lack of standardization represent obstacles to large-scale clinical implementation. The review also highlights the future prospects for integrating AI into precision medicine, favoring the development of more effective and individualized cancer treatments. It is concluded that, although the advances are promising, collaboration between health professionals and AI, the establishment of clear regulations, and the construction of consistent databases are fundamental to the success of AI in oncology.
DOI: https://doi.org/10.56238/sevened2024.039-005